Prospective, open labelled, phase II, monocenter trial to combine partial surgery resection and protontherapy to management paediatric craniopharyngioma.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
local control rate at 3 years of a minimally aggressive surgical resection, followed by fractionated high precision radiotherapy
Timeframe: at 3 years